Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Impella Comes Up Short in High-Risk PCI: CHIP-BCIS3

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow pump.

Two Oral GLP-1s Increase Options for Patient Care

Eli Lilly and Novo Nordisk are in heated competition over orforglipron versus oral semaglutide, respectively, while injectables remain the more potent obesity treatment options.

Shingles Vaccine Lowers Cardiovascular Risk

Patients with atherosclerotic cardiovascular disease who had received herpes zoster vaccination saw reductions in major adverse cardiac events.

Younger Age Offers No Protection From HFrEF Deaths

Patients with heart failure with reduced ejection fraction, especially those aged 40-49 years, have higher 5-year mortality than peers from the general population.

Active Breath Control Cuts Radiation Dose to Heart

Active breath control significantly reduced radiation dose to the heart and a major artery during treatment for left-sided breast cancer, new data show.

Hormonal Contraception and IIH Risk: New Data

A systematic review and meta-analysis sheds light on the debated association between hormonal contraception and risk for idiopathic intracranial hypertension.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow pump.

Eli Lilly and Novo Nordisk are in heated competition over orforglipron versus oral semaglutide, respectively, while injectables remain the more potent obesity treatment options.

Patients with atherosclerotic cardiovascular disease who had received herpes zoster vaccination saw reductions in major adverse cardiac events.

Patients with heart failure with reduced ejection fraction, especially those aged 40-49 years, have higher 5-year mortality than peers from the general population.

Active breath control significantly reduced radiation dose to the heart and a major artery during treatment for left-sided breast cancer, new data show.

A systematic review and meta-analysis sheds light on the debated association between hormonal contraception and risk for idiopathic intracranial hypertension.

News All Time

Guideline Offers Holistic View of Brain-Heart Comorbidities

The aim of the new guideline is to expand on current cardiovascular guidelines to include evidence from the neurologic and mental health literature.

TAVR Embolic Protection Devices Go Head to Head: PROTECT H2H

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the role of these devices remains unresolved.

Vascular Complications Tied to Poor CRC Outcomes in Diabetes

In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality.

Sleep-Aligned Fasting Linked to Cardiometabolic Benefits

An overnight fasting regimen beginning at least 3 hours prior to sleep shows potential benefits in blood pressure, heart rate dipping, and glucose regulation.

How to Get Your Daily Fiber Without Overeating

Most Americans fall short of fiber targets. Here’s how to help people understand how much they need — and how to get higher daily amounts without eating too much.

Med Op-Ed: Time Travel Edition

A 150-year-old formula for cold relief, a call for humility in the practice of preventive medicine, and one doctor’s concerns about the use of ‘informed consent.’

Indoor Air Pollution Linked to Inflammation in Heart Failure

Indoor air pollutants are associated with changes in inflammatory markers and cardiac autonomic dysregulation in people with heart failure.

5 Factors May Predict Stroke Risk Years After First Event

A new study finds hypertension, smoking history, and three ischemic stroke subtypes are linked to increased secondary stroke risk years after patients had their first minor stroke event.

Care Continuity With GPs May Improve Hypertension Detection

Continuity of care in general practice shows a dose-dependent link to higher rates and earlier detection of hypertension in adults without existing heart conditions.

FDA Okays Orforglipron for Weight Management

Eli Lilly’s orforglipron approved for adults with obesity or overweight with at least one comorbidity.

NICE Endorses Semaglutide to Reduce Cardiovascular Risk

Semaglutide recommended for NHS use in England to reduce heart attack and stroke risk in high-risk adults.

Early Acoramidis Yields Long-Term Gains in ATTR-CM

Early and continuous treatment with acoramidis is linked to lower risks for death and heart-related hospitalization than delayed treatment in patients with transthyretin amyloid cardiomyopathy.

Outdated Equipment Poses Health Risks in Fluoroscopy Labs

Is protecting clinicians actually causing harm? Experts call for a rethinking of radiation safety that also tackles the physical toll of protective gear.

AI Tool Predicts LDL Without Direct Testing

A machine learning model predicts low-density lipoprotein cholesterol from routine lab data, offering a low-cost way to identify high-risk patients.

From Prediabetes to CVD in 20 Years: The Risk Gets Real

People with impaired fasting glucose levels face a higher risk for cardiovascular diseases and the onset of diabetes than those with normal fasting glucose levels.

Recommended News For You

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

We Don't Always Know What's 'Best' for Our Patients

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

Early palliative care billing up from 2010 to 2019 for advanced cancer

Recommended Articles For You

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options  

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment 

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alkem introduces cetuximab under the trade name Cetuxa in India.

2.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

3.

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

4.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

5.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

1.

Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy

2.

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment

3.

A Visual Guide to Understanding Breast Cancer Staging

4.

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review

5.

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

4.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

5.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot